Independent Data News Today

Vasomune Therapeutics and AnGes drug candidate AV-001 Receives Positive Recommendation from the IDSMB for AV001-004 Phase 2a Study

American depositary receipts (ADRs) of Novo Nordisk (NOVO) jumped over 6% in early trading on Wednesday, while shares of kidney dialysis machine and insulin…

PRESS RELEASE MEDESIS PHARMA: FAVORABLE REPORT FROM IDSMB EXPERTS ON THE ONGOING PHASE 2 CLINICAL STUDY ON NANOLITHIUM IN THE TREATMENT OF... | May 23, 2023

Using data from the WHO ISARIC CCP-UK cohort, Dr. Lance Turtle and colleagues report on the outcome of COVID-19 in immunocompromised patients that are hospitalised.

11.08.2022 - -Sabizabulin for COVID-19 Emergency Use Authorization Application Submitted to U.S. FDA in June 2022- -The UK’s Medicines and Healthcare Products Regulatory Agency Informed the Company that its Sabizabulin Marketing Authorization Application Will ...

05.08.2022 - Conference Call and Webcast Today at 8:30 a.m. ET Dosing patients in U.S. Phase 2/3 COVAXIN (BBV152) clinical trialCompleted dosing of patients in Cohort 1 of OCU400 gene therapy product candidateExpanding product pipeline with the regenerative ...

 Independent Data and Safety Monitoring Committee Recommends Continuing Study Without Sample Size Adjustment  IDSMC Did Not Identify Any Safety ConcernsPhase 2 Study Target Enrollment Achieved; Final Data and Communication Expected in October 2023Conference Call and Webcast Today at 2:00 p.m. PDT/5:00 p.m. EDTSOUTH...

Screened approximately 700 subjects and expanding to Eastern Europe, including Turkey, as part of its clinical diversification plans to support global...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

A glance at some of the days highlights from the Proactive Investors US and Canada newswires